Status:
COMPLETED
Airway Inflammation, Small Airways Dysfunction, and Frequency of Exacerbations in COPD
Lead Sponsor:
Mansoura University Hospital
Collaborating Sponsors:
Azza Tarik Eliwa
Ahmed Elsayed Mansour
Conditions:
COPD Exacerbation Acute
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable, and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/o...
Detailed Description
Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable, and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/o...
Eligibility Criteria
Inclusion
- established diagnosis of COPD according to GOLD 2021
- Patients should quit smoking at least 6 months before enrolment in the study.
Exclusion
- Pulmonary diseases other than COPD e.g parenchymatous lung diseases
- Active smokers.
- Patients unfit for bronchoscopy.
- Immunosuppressive state and immunosuppressive therapy
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06040931
Start Date
June 1 2022
End Date
June 1 2023
Last Update
September 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of medicine Mansoura university
Al Mansurah, Egypt